Americans are tired of the pandemic and the economic, health and political fallout we have collectively experienced from it. While there may be disagreement about the best way to approach the pandemic, it is generally held that a safe, effective COVID-19 vaccine that can be manufactured and distributed at scale is a critical step toward economic recovery. … READ MORE >
life sciences
More promise, more problems: Cyberattacks threaten life sciences companies researching COVID-19 vaccine
Picture this scenario: Researchers at a biotech company are working tirelessly on a potential coronavirus vaccine and planning to start a phase three clinical trial soon. This work results in more visibility for the company, and an influx of capital investment. But with that greater visibility and investment comes added … … READ MORE >
Trump administration identifies 5 companies for government support in vaccine effort
Drug developers, academic institutions and government agencies across the globe are investigating more than 100 potential vaccines for the coronavirus. The Trump administration on Wednesday identified a handful of organizations that it believes are the most likely to produce a viable vaccine candidate, The New York Times reported. This is … … READ MORE >
Shadow IT risk is growing as health care industry consolidates
As health care systems continue to consolidate, they must be aware of the information technology risks lurking in the shadows. … READ MORE >
Biotech needs cash in hesitant market
Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. … READ MORE >